scispace - formally typeset
G

Grace C.Y. Peng

Researcher at National Institutes of Health

Publications -  21
Citations -  541

Grace C.Y. Peng is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Multiscale modeling & Health care. The author has an hindex of 10, co-authored 21 publications receiving 335 citations. Previous affiliations of Grace C.Y. Peng include Analysis Group.

Papers
More filters
Journal ArticleDOI

The State of the NIH BRAIN Initiative.

TL;DR: Scientific advances produced by individual laboratories, multi-investigator teams, and entire consortia that will produce more comprehensive and dynamic maps of the brain, deepen the understanding of how circuit activity can produce a rich tapestry of behaviors, and lay the foundation for understanding how its circuitry is disrupted in brain disorders are described.
Journal ArticleDOI

Telehealth innovations in health education and training.

TL;DR: The results of discussion on potential areas of future development, barries to overcome, and suggestions to translate the promise of telehealth applications into a transformed environment of training, education, and research in the health sciences are presented.
Journal ArticleDOI

Credible practice of modeling and simulation in healthcare: ten rules from a multidisciplinary perspective

TL;DR: Ten Rules for credible practice of modeling and simulation in healthcare are provided, developed from a comparative analysis by the Committee’s multidisciplinary membership, followed by a large stakeholder community survey, to establish a unified conceptual framework for modeled and simulation design, implementation, evaluation, dissemination and usage across the modeling and Simulation life-cycle.
Journal ArticleDOI

Epidural Spinal Stimulation to Improve Bladder, Bowel, and Sexual Function in Individuals With Spinal Cord Injuries: A Framework for Clinical Research

TL;DR: A framework for conducting the research needed to define such an effective SCS procedure that might seek Food and Drug Administration approval and be implemented at the population level is outlined.